Camurus AB (CAMRF)
Camurus AB operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $58.51, up 0.00% on the session, giving a market capitalisation of $3.48B. On trailing twelve-month figures it carries a trailing P/E of 54.70, a net margin of 29.9%. Its beta of 0.52 implies it has historically moved less than the broad market.
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Camurus AB is most often compared with the following Healthcare names: